Hypoxia-inducible factor (HIF) signaling protects the intestinal mucosa from injury induced by Clostridium difficile toxins, according to the results of a study published in Gastroenterology.

difficile infection. It is made with Lumen's proprietary spirulina-based GMP manufacturing system. Top-line results: 100% Initial Clinical Cure: 21 patients completed 7 days of LMN-201 plus ...

Recurrent CDI is an excellent example of alteration of the microbiome, which leads to disease. The use of probiotics has had limited success in treatment of this illness. By contrast, FMT has been ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

About LMN-201 and Lumen Bio LMN-201 is orally delivered (capsules; no enema or "bowel cleanse" required) and highly scalable, allowing for much broader potential use in routine CDI management.